1-(2',5'-bis-o-(tert-butyldimethylsilylribofuranosyl)-3-n-methylthymine)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide) has been researched along with HIV Coinfection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balzarini, J; Castelain, S; Duverlie, G; Fournier, C; Josse, S; Marco-Contelles, J; Moura, M; Nguyen Van Nhien, A; Postel, D; Soriano, E | 1 |
| Aquaro, S; Balzarini, J; Camarasa, MJ; Cenci, A; Clotet, B; De Clercq, E; Desmyter, J; Esnouf, RM; Hermans, P; Pelemans, H; Pérez-Pérez, MJ; Perno, CF; Ruiz, L; Schmit, JC; Sprecher, S; Van Laethem, K; Van Ranst, M; Van Wijngaerden, E; Vandamme, AM; Witvrouw, M | 1 |
2 other study(ies) available for 1-(2',5'-bis-o-(tert-butyldimethylsilylribofuranosyl)-3-n-methylthymine)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide) and HIV Coinfection
| Article | Year |
|---|---|
Synthesis and in vitro activity of novel N-3 acylated TSAO-T compounds against HIV-1 and HCV.
Topics: Cell Line; Chemistry Techniques, Synthetic; Hepacivirus; Hepatitis C; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Reverse Transcriptase Inhibitors; Small Molecule Libraries; Spiro Compounds; Thymidine; Uridine | 2011 |
Presence of 2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5"-(4"-amino-1",2"-oxath iole-2",2"-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patients.
Topics: Anti-HIV Agents; Base Sequence; DNA Primers; Drug Resistance, Microbial; Genes, Viral; Genetic Variation; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Phenotype; Point Mutation; Protein Conformation; Reverse Transcriptase Inhibitors; Spiro Compounds; Thymidine | 2000 |